The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform.
about
Dendrimer ProdrugsTweaking dendrimers and dendritic nanoparticles for controlled nano-bio interactions: potential nanocarriers for improved cancer targetingAutoimmune therapies targeting costimulation and emerging trends in multivalent therapeuticsMultifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilitiesMultivalent polymers for drug delivery and imaging: the challenges of conjugationCan nanotechnology potentiate photodynamic therapy?Design of High-Specificity Nanocarriers by Exploiting Non-Equilibrium Effects in Cancer Cell TargetingNanotechnology and cancer.Lung Cancer-Targeting Peptides with Multi-subtype Indication for Combinational Drug Delivery and Molecular ImagingTheranostic Magnetic Nanostructures (MNS) for Cancer.Selective targeting of nanocarriers to neutrophils and monocytes.Targeting and detecting cancer cells using spontaneously formed multifunctional dendrimer-stabilized gold nanoparticlesAvidity mechanism of dendrimer-folic acid conjugates.A quantitative assessment of nanoparticle-ligand distributions: implications for targeted drug and imaging delivery in dendrimer conjugates.Molecular imaging of glioblastoma multiforme using anti-insulin-like growth factor-binding protein-7 single-domain antibodies.Targeting of drugs and nanoparticles to tumors.Shaping cancer nanomedicine: the effect of particle shape on the in vivo journey of nanoparticlesA computational framework for identifying design guidelines to increase the penetration of targeted nanoparticles into tumorsKinetics of nanoparticle targeting by dissipative particle dynamics simulations.G protein-coupled receptors function as logic gates for nanoparticle binding and cell uptake.Targeted dendrimeric anticancer prodrug: a methotrexate-folic acid-poly(amidoamine) conjugate and a novel, rapid, "one pot" synthetic approachComparison of the internalization of targeted dendrimers and dendrimer-entrapped gold nanoparticles into cancer cellsBinding affinity and kinetic analysis of targeted small molecule-modified nanoparticles.Genome-free viral capsids as multivalent carriers for taxol delivery.RGD dendron bodies; synthetic avidity agents with defined and potentially interchangeable effector sites that can substitute for antibodies.Self-assembled nanoplatform for targeted delivery of chemotherapy agents via affinity-regulated molecular interactions.Isolation and characterization of dendrimers with precise numbers of functional groupsProlonged blood circulation and enhanced tumor accumulation of folate-targeted dendrimer-polymer hybrid nanoparticlesHeterobivalent ligands target cell-surface receptor combinations in vivo.Identification and characterization of receptor-specific peptides for siRNA delivery.Nanoparticle design optimization for enhanced targeting: Monte Carlo simulations.Nanoparticles targeting dendritic cell surface molecules effectively block T cell conjugation and shift response.Effect of Mass Transport in the Synthesis of Partially Acetylated Dendrimer: Implications for Functional Ligand-Nanoparticle Distributions.Convergent assembly and surface modification of multifunctional dendrimers by three consecutive click reactions.Direct measurements on CD24-mediated rolling of human breast cancer MCF-7 cells on E-selectin.Design, synthesis, and biological functionality of a dendrimer-based modular drug delivery platform.Aptamer-mediated up-conversion core/MOF shell nanocomposites for targeted drug delivery and cell imagingMacrocyclic chelator assembled RGD multimers for tumor targeting.Magnetic Iron Oxide Nanoworms for Tumor Targeting and Imaging.Exploring cancer metastasis prevention strategy: interrupting adhesion of cancer cells to vascular endothelia of potential metastatic tissues by antibody-coated nanomaterial.
P2860
Q26743392-C1D8C068-DC0A-49F1-A0ED-1DA2A83CB875Q26785347-1C3A7E14-4B5E-47DE-AC85-23C440E9F5B2Q26823789-2AD26ED9-66BA-4A71-8FD1-B1B2E6B422D9Q27011598-4684D189-709F-4877-92D2-E0BD48616D0AQ27692689-240193CD-1D3F-40CA-A60C-887F1073EF00Q28388084-5E2C19A6-4C30-498E-A6B3-06D949E1FF59Q28534332-F0002783-A38E-4F33-BAC1-4A86E4A99D3AQ30452478-F463F492-B5B6-40B4-A854-0A66B19BF2F1Q30851553-CA84AF9A-25F9-4E86-B391-8544EFA0DD9DQ30937214-5663D7E3-1D25-43D5-9908-D8DA20EC1791Q33433964-E84F1649-9821-4999-9C6F-ECB3FA1FD339Q33475678-671F3834-AEDB-48CC-B7B7-C59ABF86AA64Q33598717-93F9E5A7-4130-4FB6-8621-B051BC8A5DBDQ33718722-BBAB3444-1D75-48C5-80B2-E976B0901F90Q33722980-060A8776-41A0-4534-A7F2-B968832260B8Q33751710-F81AF80B-2422-4D38-B70B-F246086DAA81Q33755231-75129A21-97CD-4471-9DC7-B24E887F40ADQ33855309-116F2680-7AB1-4D73-ABD2-C66835B168FEQ33881923-07D960C8-ACAF-4F42-9012-462B1DABE74BQ33934981-42FCE36E-6D2A-47AA-9CF1-FF2313C61321Q33941281-FC0F5244-207F-45EC-A9F3-DA3DCA404B0CQ33983843-5E011E85-7998-4F40-B8BC-7791B432154CQ33985752-8564858E-5480-4717-A5F1-735F49701016Q34057731-34CAAE5E-9C18-4CAB-BFC9-50A9445ED71EQ34062177-C01BFB49-7571-4AC0-ABFB-EAF333FC6B82Q34077808-50AAB4F4-83E0-4720-B84F-AC8318077856Q34142960-6A8DC272-726E-40A1-8CA5-59D71E8B7A98Q34145405-D602A15A-26EA-4F97-8737-3384691E41A8Q34317386-D9FB36D2-F054-4546-AB65-1BE99D6DC8B3Q34386810-4D724A05-082B-4D82-A256-AF5FF5C20D06Q34391939-8EFAA44B-F4A8-4859-8BC0-9626A3133C97Q34394867-2A2A8AEC-B5E2-458E-897F-52867AAB8BA8Q34666766-2330D2B7-36CB-4441-8166-271C74F61EAEQ34685535-34B68254-C266-4F0C-8B41-8418B1FCFDACQ34687251-E46C0897-3FE4-4173-996C-6C22D9068D1AQ34952473-D79B87D1-08B9-4BD3-B78A-C0A14CDC7A95Q34981045-5248499C-3A7E-474E-BAEE-17A46B00DCE3Q34995512-8C1419B4-0842-4C98-9DE7-C65384A1DE2BQ35047373-D202B092-8646-42CD-9E55-F6E25DD8CA99Q35059932-105034B8-991E-4394-9102-28179F359967
P2860
The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform.
@en
type
label
The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform.
@en
prefLabel
The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform.
@en
P2093
P1476
The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform
@en
P2093
Bradford G Orr
István J Majoros
James R Baker
Pascale R Leroueil
Seungpyo Hong
P304
P356
10.1016/J.CHEMBIOL.2006.11.015
P577
2007-01-01T00:00:00Z